---
id: 1523384935717150720
author: hmatejx
published_date: 2022-05-08 19:30:46 +00:00
conversation_id: 1522997158550462466
in_reply_to: 1523383344326594560
retweet: None
quoted_tweet: None
type: tweet
tags:
-
---

@stephensenn @yudapearl @RWJE_BA Good point, so the question is how to describe two separate studies that happen to share a treatment (in TARGET case it was lumiracoxib). They might as well be TARGET1 and TARGET2. Also what would be the common estimate of interest?

### Metadata

Author: [[@hmatejx]]
Conversation: [[conversation-1522997158550462466]]
In reply to: [[1523383344326594560]]
Retweet of: [[None]]
Quoted tweet: [[None]]
